RECK Polyclonal Antibody

    • Catalog No.:YT4036
    • Applications:IHC;IF;WB;ELISA
    • Reactivity:Human;Mouse
      • Target:
      • RECK
      • Fields:
      • >>MicroRNAs in cancer
      • Gene Name:
      • RECK
      • Protein Name:
      • Reversion-inducing cysteine-rich protein with Kazal motifs
      • Human Gene Id:
      • 8434
      • Human Swiss Prot No:
      • O95980
      • Mouse Swiss Prot No:
      • Q9Z0J1
      • Immunogen:
      • The antiserum was produced against synthesized peptide derived from human RECK. AA range:21-70
      • Specificity:
      • RECK Polyclonal Antibody detects endogenous levels of RECK protein.
      • Formulation:
      • Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
      • Source:
      • Polyclonal, Rabbit,IgG
      • Dilution:
      • WB 1:500-2000 IHC 1:100 - 1:300. IF 1:200 - 1:1000. ELISA: 1:20000. Not yet tested in other applications.
      • Purification:
      • The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
      • Concentration:
      • 1 mg/ml
      • Storage Stability:
      • -15°C to -25°C/1 year(Do not lower than -25°C)
      • Other Name:
      • RECK;ST15;Reversion-inducing cysteine-rich protein with Kazal motifs;hRECK;Suppressor of tumorigenicity 15 protein
      • Observed Band(KD):
      • 110kD
      • Background:
      • The protein encoded by this gene is a cysteine-rich, extracellular protein with protease inhibitor-like domains whose expression is suppressed strongly in many tumors and cells transformed by various kinds of oncogenes. In normal cells, this membrane-anchored glycoprotein may serve as a negative regulator for matrix metalloproteinase-9, a key enzyme involved in tumor invasion and metastasis. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015],
      • Function:
      • function:Negatively regulates matrix metalloproteinase-9 (MMP-9) by suppressing MMP-9 secretion and by direct inhibition of its enzymatic activity. RECK down-regulation by oncogenic signals may facilitate tumor invasion and metastasis. Appears to also regulate MMP-2 and MT1-MMP, which are involved in cancer progression.,PTM:N-glycosylated.,similarity:Contains 3 Kazal-like domains.,subunit:Interacts with MMP-9.,tissue specificity:Expressed in various tissues and untransformed cells. It is undetectable in tumor-derived cell lines and oncogenically transformed cells.,
      • Subcellular Location:
      • Cell membrane ; Lipid-anchor, GPI-anchor .
      • Expression:
      • Expressed in various tissues and untransformed cells (PubMed:9789069). It is undetectable in tumor-derived cell lines and oncogenically transformed cells (PubMed:9789069).
      • Products Images
      • Immunofluorescence analysis of HepG2 cells, using RECK Antibody. The picture on the right is blocked with the synthesized peptide.
      • Immunohistochemistry analysis of paraffin-embedded human brain tissue, using RECK Antibody. The picture on the right is blocked with the synthesized peptide.